TRAW
Traws Pharma, Inc.
-0.00 (-0.36%)0.53USD39.0K成交股數8.1M市值–本益比(近四季)2.9股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | 2.7M+4780% | 57K+2% | 57K0% | 57K0% | 56K | 56K | 57K | 57K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.1M | 4.9M | 5.0M | 2.3M | 2.3M | 2.5M | 5.1M | 4.0M | 1.9M | 2.4M | 2.5M | 2.5M |
| 銷售管理費用 | 3.5M | 2.0M | 2.3M | 1.7M | 1.7M | 2.8M | 3.5M | 2.0M | 3.4M | 2.1M | 2.7M | 2.2M |
| 營業利益 | −3.2M+154% | −6.9M+33% | −7.4M-14% | −4.1M-97% | −1.2M-76% | −5.2M+17% | −8.5M+68% | −123M+2576% | −5.2M | −4.5M | −5.1M | −4.6M |
| 營業利益率 | – | – | – | – | -45.7% | -9,128.1% | -14,975.4% | -216,400.0% | -9,307.1% | -7,967.9% | -8,928.1% | -8,087.7% |
| 稅後淨利 | −3.1M+234% | −7.1M-133% | −7.4M-12% | −4.0M-97% | −915K-82% | 21.5M-614% | −8.5M+79% | −123M+2797% | −5.0M | −4.2M | −4.7M | −4.3M |
| 淨利率 | – | – | – | – | -33.5% | 37,701.8% | -14,868.4% | -216,040.4% | -8,898.2% | -7,471.4% | -8,314.0% | -7,456.1% |
| 稀釋 EPS | -0.16+45% | -0.53-125% | -0.82-45% | -0.34-98% | -0.11-98% | 2.09-113% | -1.49-74% | -20.52+10160% | -5.92 | -16.45 | -5.64 | -0.20 |
| 稀釋股數 | 15.9M | 10.6M | 8.4M | 8.8M | 5.8M | 7.2M | 962K | 1.0M | 842K | 840K | 840K | 21.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 5.0M | 3.1M | 3.8M | 6.4M | 13.1M | 15.9M | 5.4M | 16.9M | 16.4M | 20.6M | 25.2M | 29.7M |
| 應收帳款 | 3.5M | 1.7M | 3.8M | 2.0M | 1.3M | 1.7M | 2.1M | 18K | 18K | 18K | 18K | 17K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 11.5M | 8.2M | 10.6M | 12.4M | 15.6M | 19.1M | 8.9M | 18.7M | 18.2M | 22.7M | 27.0M | 30.5M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 9.8M | 13.5M | 11.2M | 7.9M | 7.4M | 13.1M | 11.0M | 12.6M | 12.2M | 12.0M | 12.5M | 11.6M |
| 股東權益 | 1.7M | −5.3M | −629K | 4.5M | 8.3M | 6.0M | −2.0M | −106M | 6.0M | 10.7M | 14.5M | 18.9M |
| 負債比 | 85.3% | 165.1% | 105.9% | 63.5% | 47.1% | 68.5% | 122.8% | 67.4% | 66.9% | 53.0% | 46.3% | 38.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.6M-53% | – | – | – | −5.4M | – | – | −4.4M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 44K | – | – | – | 1K | – | – | 4K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 2.8M
| Single Reportable | 2.8M | 100.0% | +1134.5% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.8M | +1134.5% | 9.2M | 328.7% | 0.82 | −20.8M |
| FY2024 | 226K | 0.0% | −167M | -73,682.7% | -35.21 | −33.4M |
| FY2023 | 226K | 0.0% | −18.9M | -8,384.1% | -22.57 | −17.9M |
| FY2022 | 226K | 0.0% | −19.0M | -8,391.2% | -0.91 | – |
| FY2021 | 226K | -2.2% | −16.2M | -7,151.8% | -0.96 | – |
| FY2020 | 231K | -89.4% | −25.2M | -10,890.5% | -2.17 | −23.1M |
| FY2019 | 2.2M | +77.8% | −21.5M | -985.0% | -1.49 | −20.9M |
| FY2018 | 1.2M | – | −20.6M | -1,675.3% | -4.99 | – |